ARTICLE

Modified ASRA facilitates the characterization of activating point mutations in tumors, in which cancer cells constitute only a minor part of the investigated tissue.

    • Institute of Toxicology, University of Würzburg, Germany.
Published October 1, 1993. Vol 3 Issue 2, pp. 125-126. https://doi.org/10.1101/gr.3.2.125
Download PDF Cite Article Permissions Share
Alerts Please log-in to or register for your personal account in order to apply an alert.Log-in/register
cover of Genome Research Vol 36 Issue 8
Current Issue:
August 2026, Vol. 36, No. 8
Article contents

Announcement(s)